Open Journal Systems





Transferrin receptor cluster of differentiation 71: A potential novel target for bladder cancer

VIEWS - 49 (Abstract) 30 (PDF)
Haixiao Guo, Yuhang Gong, Haifeng Wang, Jiansong Wang, Zhao Yang, Chong Li

Abstract


Cluster of differentiation 71 (CD71) is important to the proliferation of many tumors and could be a potential target for tumor diagnosis. This study aimed to investigate the level of CD71 expression in bladder cancer (BC) tissues and urine samples for initial detection of BC. Eighty-seven bladder tumor tissues and 219 urine samples were collected from patients diagnosed with BC in the Urology Department of the Second Affiliated Hospital of Kunming Medical University. Quantitative real-time reverse transcription PCR (qRT-PCR), immunohistochemistry (IHC), and enzyme-linked immunosorbent assay were used to detect the gene and protein expression levels of CD71 in BC tissues and urine samples. Chi-square test was then carried out for analyses. Compared with non-BC samples, the expression levels of CD71 in BC tissues and urine increased significantly (P<0.050). In conclusion, CD71 was highly expressed in BC tissues and urine. Thus, the concentrations of urine CD71 could be a new target for clinical detection of BC.


Keywords


bladder cancer; Cluster of Differentiation 71(CD71); Urine diagnosis

Full Text:

PDF

References


Miyamoto DT, Mouw KW, Feng FY, et al., 2018, Molecular Biomarkers in Bladder Preservation Therapy for Muscle-invasive Bladder Cancer. Lancet Oncol, 19(12):e683-95. DOI 10.1016/s1470-2045(18)30693-4.

Bray F, Ferlay J, Soerjomataram I, et al., 2018, Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 68(6):394-424. DOI 10.3322/ caac.21492.

Zhang S, Du L, Wang L, et al., 2019, Evaluation of Serum Exosomal LncRNA-based Biomarker Panel for Diagnosis and Recurrence Prediction of Bladder Cancer. J. Cell Mol Med, 23(2):1396-405. DOI 10.1111/jcmm.14042.

Li T, Zou L, Zhang J, et al., 2019, Non-invasive Diagnosis of Bladder Cancer by Detecting Telomerase Activity in Human Urine Using Hybridization Chain Reaction and Dynamic Light Scattering. Anal Chim Acta, 1065:90-7. DOI 10.1016/j.aca.2019.03.039.

Bravaccini, S, Casadio V, Gunelli R, et al., 2011, Combining Cytology, TRAP Assay, and FISH Analysis for the Detection of Bladder Cancer in Symptomatic Patients. Ann Oncol, 22(10):2294-8. DOI 10.1093/annonc/mdq740.

Montemiglio LC, Testi C, Ceci P, et al., 2019, Cryo-EM Structure of the Human Ferritin-transferrin Receptor 1 Complex. Nat Commun 10:1121. DOI 10.1038/s41467- 019-09098-w.

Neiveyans M, Melhem R, Arnoult C, et al., 2019, A Recycling Anti-transferrin Receptor-1 Monoclonal Antibody as an Efficient Therapy for Erythroleukemia Through Target up-regulation and Antibody-dependent Cytotoxic Effector Functions. MAbs, 11(3):593-605. DOI 10.1080/19420862.2018.1564510.

Kleven MD, Jue S, Enns CA, 2018, Transferrin Receptors TfR1 and TfR2 Bind Transferrin through Differing Mechanisms. Biochemistry, 57(9):1552-9. DOI 10.1021/ acs.biochem.8b00006.

Miyazawa M, Bogdan AR, Hashimoto K, et al., 2018, Regulation of Transferrin Receptor-1 mRNA by the Interplay Between IRE-binding Proteins and miR-7/ miR-141 in the 3’-IRE Stem-loops. RNA, 24(4):468-79. DOI 10.1261/rna.063941.117.

Fillebeen, C, Charlebois E, Wagner J, et al., 2019, Transferrin Receptor 1 Controls Systemic Iron Homeostasis by Fine-tuning Hepcidin Expression to Hepatocellular Iron Load. Blood, 133:344-55. DOI 10.1182/blood-2018-05-850404.

Jeong SM, Hwang S, Seong RH, 2016, Transferrin Receptor Regulates Pancreatic Cancer Growth by Modulating Mitochondrial Respiration and ROS Generation. Biochem Biophys Res Commun, 471:373-9. DOI 10.1016/j.bbrc.2016.02.023.

Shen Y, Li X, Dong D, et al., 2018, Transferrin Receptor 1 in Cancer: A New Sight for Cancer Therapy. Am J Cancer Res, 8(6):916-31.

Chen W, Zheng R, Baade PD, et al., 2016, Cancer Statistics in China, 2015. CA Cancer J Clin, 66(2):115-32. DOI 10.3322/caac.21338.

Oeyen, E, Hoekx L, De Wachter S, et al., 2019, Bladder Cancer Diagnosis and Follow-up: The Current Status and Possible Role of Extracellular Vesicles. Int J Mol Sci, 20(4):e821. DOI 10.3390/ijms20040821.

Santoni G, Morelli MB, Amantini C, et al., Urinary Markers in Bladder Cancer: An Update. Front Oncol, 8:362. DOI 10.3389/fonc.2018.00362.

Dunsmore G, Koleva P, Ghobakhloo N, et al., 2019, Lower Abundance and Impaired Function of CD71+ Erythroid Cells in Inflammatory Bowel Disease Patients During Pregnancy. J Crohns Colitis, 13(2):230-44. DOI 10.1093/ ecco-jcc/jjy147.

Babu KR, Muckenthaler MU, 2019, miR-148a Regulates Expression of the Transferrin Receptor 1 in Hepatocellular Carcinoma. Sci Rep, 9:1518. DOI 10.1038/s41598-018- 35947-7.

Basuli D, Tesfay L, Deng Z, et al., 2017, Iron Addiction: A Novel Therapeutic Target in Ovarian Cancer. Oncogene, 36(29):4089-99. DOI 10.1038/onc.2017.11.




DOI: http://dx.doi.org/10.18063/c+.v1i2.237

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Haixiao Guo, Yuhang Gong, Haifeng Wang, Jiansong Wang, Zhao Yang, Chong Li

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Recent Articles | About Journal | For Author | Fees | About Whioce

Copyright © Whioce Publishing Pte Ltd. All Rights Reserved.